Navigation Links
Luminex Corporation Reports Third Quarter 2011 Results
Date:11/1/2011

inty regarding the outcome or expense of any litigation brought against Luminex, risks relating to Luminex's foreign operations, risks and uncertainties associated with implementing our acquisition strategy and the ability to integrate acquired companies, or selected assets into our consolidated business operations, including the ability to recognize the benefits of our acquisitions, as well as the risks discussed under the heading "Risk Factors" in Luminex's Reports on Forms 10-K and 10-Q, as filed with the Securities and Exchange Commission.  The forward-looking statements, including the financial guidance and 2011 outlook, contained herein represent the judgment of Luminex as of the date of this press release, and Luminex expressly disclaims any intent, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in Luminex's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.Contacts:

Harriss T. Currie

Matthew ScaloVice President, Finance and Chief Financial Officer

Sr. Director of Investor Relations512-219-8020

512-219-8020hcurrie@luminexcorp.com

mscalo@luminexcorp.com LUMINEX CORPORATIONCONDENSED CONSOLIDATED BALANCE SHEETS(in thousands)September 30,December 31,20112010(unaudited)ASSETSCurrent assets:Cash and cash equivalents

$
5,081$
89,487Restricted cash

1,0051,002Short-term investments

31,58428,404Accounts receivable, net

20,90920,936Inventories, net

25,97524,932Deferred income taxes

3,2634,225Prepaids and other

3,2422,732Total current assets

151,059171,718Property and equipment, net

24,97222,084Intangible assets, net

30,59112,944Deferred income taxes

13,5156,363Long-term investments

11,7056,021Goodw
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Luminex Corporation Receives Deloitte Technology Fast 500™ Award
2. Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
3. Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna
4. Luminex Corporation to Present at Upcoming Investment Conferences In September
5. Luminex Corporation Reports Second Quarter 2011 Results
6. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
7. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
8. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
9. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
10. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
11. Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015 UPM Pharmaceuticals, a division of ... Sprout Pharmaceuticals to manufacture Flibanserin 100 mg tablets. Sprout ... the first drug approved to treat hypoactive sexual desire ... dysfunction. The tablets will be manufactured at ... Tennessee . Dr. John M. ...
(Date:3/4/2015)... 4, 2015 Following the reintroduction of ... Center (LAC) released a report today urging policymakers ... and heroin epidemic through more effective use of ... "The Case for Expanding Access to Medication-Assisted Treatment ... the health, justice, and economic advantages of medication-assisted ...
(Date:3/4/2015)... 2015  Heska Corporation (Nasdaq: HSKA ) ... Join Its Fourth Quarter and Year End 2014 Earnings ... 9:00 a.m. (MST) / 11:00 a.m. (EST)Where: www.heska.com ... Call link on the front page of this website)How:Live ... web at the address above.  Alternatively, you may use ...
Breaking Medicine Technology:UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 3Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2
... , MELVILLE, N.Y. , Jan. 25 ... provider of health care products and services to office-based practitioners, announced today ... and Chief Financial Officer, will present at the Jefferies 2010 Global Healthcare ... Schein,s presentation is scheduled to begin at 3:30 p.m. EST ...
... , , RYE, N.Y. , ... a drug research and development company focused on the treatment of neurological ... clinical trials for CM-AT, its autism treatment, at ten sites across the ... New York City Drexel University , Philadelphia ...
Cached Medicine Technology:Henry Schein To Present At The Jefferies 2010 Global Healthcare Services Conference 2Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites 2Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites 3Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites 4
(Date:3/4/2015)... Vancouver chiropractic clinic, Backs in Action ... the prestigious Vancouver Courier “Stars of Vancouver” 2015 ... company secured third place in the “Best Chiropractor” ... Massage Therapist” category. , As one of ... Vancouver Courier is a semiweekly local newspaper published ...
(Date:3/4/2015)... 04, 2015 " Optrix by Body ... its monthly Tech Report, which takes a look at ... to consumers. Scott Steinberg, a special reporter for NewsWatch ... shared with viewers how they have an ultra-rugged, waterproof ... industry is a major player at the Consumer Electronics ...
(Date:3/4/2015)... March 04, 2015 The Global ... billion in 2014 and is estimated to grow ... of 4.0% from 2014 to 2019. , Browse ... Market for an analysis of industry trends, segments ... global liquefied petroleum gas market is classified into ...
(Date:3/4/2015)... Organic Valley, the nation’s largest cooperative of ... cause campaign to Save the Bros, http://savethebros.com/ with ... difference to Bros everywhere. To date, the video has ... The video was named Adweek’s best commercial of the week ... Digiday, among other media outlets. , “We are pleased ...
(Date:3/4/2015)... Columbus is no stranger to drug addiction. The ... addiction, and suffers from the potential threat of Kratom. In ... DEA revealed that Kratom is a “drug of concern.” Although ... introduced herb from Southeast Asia acts as a stimulant in ... kratom foments symptoms similar to heroin withdrawal, and includes tremors, ...
Breaking Medicine News(10 mins):Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 3Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2
... , , IRVINE, Calif., Aug. ... share of $0.49 for the quarter ended June 30, 2009, a 24% ... The Company reported quarterly revenues of $81 million, a 4% increase compared ... , The Company,s results are reflective of improved growth ...
... an increased risk of death, found a new study of ... in CMAJ ( Canadian Medical Association Journal ) ... approximately 25% of people (both men and women) living in ... develop a spine fracture will die over a 5 year ...
... ... their already booming empire of top physicians. The much awaited International Association of Dermatologists ... their renowned directory, "The Leading Physicians Of the World". , ... New York, NY (PRWEB) August 3, 2009 ...
... , , CHICAGO, Aug. 3 Eczema ... rashes. It is commonly known as "the itch that rashes." (1) ... appears to result from a complex interaction of factors including personal and ... Scratching the affected area can lead to more itch, redness, swelling, ...
... Commentary by Betsy McCaughey ,rife with gross, cruel distortions, ... York State Director Lois Aronstein issued the following statement in response to ... reform measures passed or currently being considered by Congress. , , ... various media outlets is rife with gross -- and even cruel -- ...
... , , , ... N.C., Aug. 3 Kowa Research Institute (KRI) based in ... specialty pharmaceutical company headquartered in Montgomery, AL, announced today that ... (R) (pitavastatin), a potent HMG-CoA reductase inhibitor (statin), for ...
Cached Medicine News:Health News:CorVel Announces Revenues and Earnings 2Health News:CorVel Announces Revenues and Earnings 3Health News:CorVel Announces Revenues and Earnings 4Health News:CorVel Announces Revenues and Earnings 5Health News:Hip and back fractures increase mortality rates in people older than 50 2Health News:Top Dermatologists to be Selected and Published in "The Leading Physicians of the World" Consumer Directory. 2Health News:Five Questions About Eczema 2Health News:Five Questions About Eczema 3Health News:Five Questions About Eczema 4Health News:Five Questions About Eczema 5Health News:AARP Responds to Health Reform Scare Tactics 2Health News:AARP Responds to Health Reform Scare Tactics 3Health News:FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia 2Health News:FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia 3Health News:FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia 4
The Medtronic EOPA CAP® arterial cannula provides a simple solution to obtaining accurate arterial pressure readings....
Intermittent catheter...
Intermittent catheter...
... new dimension in vitreoretinal surgery. ,By ... of purified perfluoro-n-octane, you can greatly ... ideal for managing retinal detachments complicated ... and trauma. , ,Certified to be ...
Medicine Products: